Viola Vitalis AB
Founded in 2010, Viola Vitalis AB develops and disseminates leading-edge innovative technology, methodology, and nutraceuticals gloabally. We have carried out successful projects, collaborated with renowned organizations, and delivered services and solutions worldwide in the field of scientific and industrial research. In collaboration with preeminent global innovation leaders, we have developed effective nutraceuticals, mediated sales of state-of-the-art healthcare technologies and laboratory equipment, and provided analytical services.
Viola Vitals AB
Science put to use
Viola Vitalis AB initiated the development of a turnkey system for human milk banks leveraging state-of-the-art technology to help minimize infant mortality, particularly among preterm infants. The prime purpose of our research on nutraceuticals is to develop sustainable protection against chronic diseases such as Arsenicosis, affecting over 100 million people globally.
1. As a combined collaboration of the Department of Social Services and Nobojibon, the “Awareness and Medical Management of Arsenicosis Patients” project under the Ministry of Social Welfare started in the fiscal year 2021–2022 with the active assistance of Viola Vitalis.
2. Administrative and procurement operations for the project titled “Awareness and Medical Management of Arsenicosis Patients” was completed on June 2022.
3. Project director Md. Zahirul Islam stated that all field-level implementation work, treatment of Arsenicos, testing, and research will begin in August 2022.
What We Do
Make the World a Better Place with the Blessing of Science
In the 21st century, unparalleled innovations in incremental and disruptive technology can combat malnutrition, disease, and death better than at any other time in history. We develop, disseminate, and mediate the sales and distribution of such leading-edge technology and provide healthcare and other solutions in the process.